MET is an oncogene that, when activated by its ligand HGF, exhibits potent migration/invasion-inducing activity and is frequently expressed in OS and is strictly related to its aggressiveness [27], and found relevant for the pathogenesis of this tumor [28, 29]. The gene discussed is HGF; the disease is neoplasm.